{"id":1683,"date":"2025-08-05T08:56:51","date_gmt":"2025-08-05T15:56:51","guid":{"rendered":"https:\/\/knightlab.ucsd.edu\/?p=1683"},"modified":"2025-08-05T08:57:24","modified_gmt":"2025-08-05T15:57:24","slug":"tracking-microbial-rhythms-reveals-new-target-for-treating-metabolic-diseases","status":"publish","type":"post","link":"https:\/\/knightlab.ucsd.edu\/?p=1683","title":{"rendered":"Tracking Microbial Rhythms Reveals New Target for Treating Metabolic Diseases"},"content":{"rendered":"<p><span style=\"color: #999999;\"><a style=\"color: #999999;\" href=\"https:\/\/today.ucsd.edu\/story\/tracking-microbial-rhythms-reveals-new-target-for-treating-metabolic-diseases\"><span style=\"text-decoration: underline;\"><strong>Researchers harness the benefits of time-restricted feeding on the gut microbiome &#8211; with the ultimate goal of developing new therapies for obesity, diabetes and related diseases &#8212; <em>featuring Rob Knight as an additional co-author on the study<\/em><\/strong><\/span><\/a><\/span><\/p>\n<p><span style=\"color: #999999;\">The gut microbiome, a vast assortment of bacteria and other microorganisms that inhabit our digestive system, plays a critical role in converting food into energy. Many of these microbes follow rhythmic cycles of activity throughout the day. However, high-fat diets and other factors can disrupt these rhythms and contribute to metabolic disease.<\/span><\/p>\n<p><span style=\"color: #999999;\">A new study by researchers at University of California San Diego and their colleagues used time-restricted feeding (TRF), an intervention that limits dietary intake to a short time window each day, to restore microbial rhythms in mice fed a high-fat diet. By analyzing daily fluctuations in microbial gene expression, they identified a specific enzyme \u2014 a bile salt hydrolase (BSH) \u2014 that appears to play a role in protecting metabolic health.<\/span><\/p>\n<p><span style=\"color: #999999;\">They then engineered the <em>bsh<\/em> gene into a harmless gut bacterium and found that mice given this modified microbe had less body fat, better insulin sensitivity and improved glucose control, thereby mimicking the effects of time-restricted feeding. The findings could contribute to the development of targeted therapies for obesity, diabetes and other metabolic conditions in humans. The study was published in <a style=\"color: #999999;\" href=\"https:\/\/www.cell.com\/cell-host-microbe\/fulltext\/S1931-3128(25)00207-0\">Cell Host &amp; Microbe<\/a> on June 18, 2025.<\/span><\/p>\n<p><span style=\"color: #999999;\">To explore how TRF affects microbial function, the researchers used a technique called metatranscriptomics, which measures real-time gene expression in gut bacteria. Because TRF changes the timing of food intake, the team hypothesized that it would drive time-sensitive shifts in microbial activity that conventional methods can\u2019t capture. To test this, they studied gut microbiome function in three groups of mice: one fed a high-fat diet under TRF (eight hours per day), one fed the same diet with food available all day long, and a control group fed a standard diet with unrestricted access.<\/span><\/p>\n<p><span style=\"color: #999999;\">Read <a style=\"color: #999999;\" href=\"https:\/\/today.ucsd.edu\/story\/tracking-microbial-rhythms-reveals-new-target-for-treating-metabolic-diseases\"><span style=\"text-decoration: underline;\">full article<\/span><\/a><\/span><\/p>\n<p><span style=\"color: #999999;\">Additional co-authors on the study include: Nicole Siguenza, Wuling Zhong, Amulya Lingaraju, R. Alexander Richter, Smruthi Karthikeyan, April L. Lukowski, Ipsita Mohanty, Wilhan D.G. Nunes, Jasmine Zemlin, Zhenjiang Zech Xu, Jeff Hasty, Pieter C. Dorrestein and <span style=\"color: #ffffff;\"><strong>Rob Knight at UC San Diego<\/strong><\/span>; Satchidananda Panda at the Salk Institute for Biological Studies; and Qiyun Zhu at Arizona State University.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Researchers harness the benefits of time-restricted feeding on the gut microbiome &#8211; with the ultimate goal of developing new therapies for obesity, diabetes and related diseases &#8212; featuring Rob Knight<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-1683","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/knightlab.ucsd.edu\/index.php?rest_route=\/wp\/v2\/posts\/1683","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/knightlab.ucsd.edu\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/knightlab.ucsd.edu\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/knightlab.ucsd.edu\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/knightlab.ucsd.edu\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1683"}],"version-history":[{"count":2,"href":"https:\/\/knightlab.ucsd.edu\/index.php?rest_route=\/wp\/v2\/posts\/1683\/revisions"}],"predecessor-version":[{"id":1685,"href":"https:\/\/knightlab.ucsd.edu\/index.php?rest_route=\/wp\/v2\/posts\/1683\/revisions\/1685"}],"wp:attachment":[{"href":"https:\/\/knightlab.ucsd.edu\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1683"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/knightlab.ucsd.edu\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1683"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/knightlab.ucsd.edu\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1683"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}